Concepedia

Mohamed Darif

MD

Statistics

Publications

17

Citations

1.1K

H-Index

14

Active since

1994

Affiliations

Northwestern University(Current)

Biogen (United States)

Mayo Clinic in Arizona

University of California, Los Angeles

Fox Chase Cancer Center

Mohamed Darif is an author at Northwestern University specializing in medicine, oncology, and immunotherapy.

Publications per year

1994–2022

17

Publications

17

Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study

Leo I. Gordon, Arturo Molina, Thomas E. Witzig et al. · Blood · 2004 · 189 citations · Full text

Medicine, Immunology, Oncology +9

Long‐term responses in patients with recurring or refractory B‐cell non‐Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan

Thomas E. Witzig, Arturo Molina, Leo I. Gordon et al. · Cancer · 2007 · 176 citations

Medicine, Oncology, Pharmacotherapy +15

Treatment-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Patients Treated With Ibritumomab Tiuxetan Radioimmunotherapy

Myron S. Czuczman, Christos Emmanouilides, Mohamed Darif et al. · Journal of Clinical Oncology · 2007 · 145 citations · Full text

Medicine, Hematology, Oncology +13

Yttrium 90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Produces High Response Rates and Durable Remissions in Patients with Previously Treated B-Cell Lymphoma

Leo I. Gordon, Thomas E. Witzig, Arturo Molina et al. · Clinical Lymphoma · 2004 · 121 citations

Medicine, Immunology, Oncology +11

Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Paul G. Richardson, Shaji Kumar, Tamás Masszi et al. · Journal of Clinical Oncology · 2021 · 99 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

1–5 of 17